SA PRO
Free Account
Ocular Therapeutix, Inc.OCULNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 88% recommend buying.

Consensus Rating
Buy
17 analysts·Moderate coverage
88%
Rating Distribution
Strong Buy
16%
Buy
1482%
Hold
212%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 187% higher.

Bear Case
$21.00
+130%
Consensus
$26.25
+187%
Bull Case
$31.00
+239%
Price Range17 analysts
Low
Consensus
High
$21.00
$31.00
Current Target
Current Price
$9.15
Upside to Target
$17.10

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 8, 2025H.C. Wainwright
Ocular Therapeutix price target raised to $21 from $19 at H.C. Wainwright
Target:$21.00
+66.9%from $12.58
Oct 8, 2025H.C. Wainwright
Ocular Therapeutix price target raised to $19 from $15 at H.C. Wainwright
Target:$19.00
+64.9%from $11.52
Oct 3, 2025Piper Sandler
Ocular Therapeutix price target raised to $31 from $21 at Piper Sandler
Target:$31.00
+180.3%from $11.06
Oct 3, 2025Robert W. Baird
Ocular Therapeutix price target raised to $24 from $17 at Baird
Target:$24.00
+117.0%from $11.06
Oct 1, 2025JMP Securities
Ocular Therapeutix price target raised to $29 from $20 at Citizens JMP
Target:$29.00
+148.1%from $11.69
Mar 4, 2025JMP Securities
Ocular Therapeutix price target lowered to $19 at Citizens JMP, buy on weakness
Target:$19.00
+192.3%from $6.50
Aug 8, 2024Robert W. Baird
Ocular Therapeutix price target lowered to $17 from $18 at Baird
Target:$17.00
+103.1%from $8.37
Jun 27, 2024Piper Sandler
Piper Sandler Reiterates Overweight Rating on Ocular Therapeutix (OCUL)
Target:$15.00
+123.5%from $6.71
Jun 14, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)
Target:$14.00
+137.8%from $5.89
Mar 12, 2024JMP Securities
Ocular Therapeutix (OCUL) PT Raised to $24 at JMP Securities
Target:$24.00
+158.3%from $9.29
Jun 7, 2022Piper Sandler
Ocular Therapeutix (OCUL) Stock Price: $10 Target And Overweight Rating
Target:$10.00
+164.6%from $3.78

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance